Structural Implications of STAT3 and STAT5 SH2 Domain Mutations.

SH2 domain STAT3 STAT5 T-cell large granular lymphocytic leukemia T-cell prolymphocytic leukemia autosomal-dominant hyper IgE syndrome cancer growth hormone insensitivity syndrome inflammatory hepatocellular adenomas mutations

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
08 Nov 2019
Historique:
received: 30 09 2019
revised: 02 11 2019
accepted: 05 11 2019
entrez: 14 11 2019
pubmed: 14 11 2019
medline: 14 11 2019
Statut: epublish

Résumé

Src Homology 2 (SH2) domains arose within metazoan signaling pathways and are involved in protein regulation of multiple pleiotropic cascades. In signal transducer and activator of transcription (STAT) proteins, SH2 domain interactions are critical for molecular activation and nuclear accumulation of phosphorylated STAT dimers to drive transcription. Sequencing analysis of patient samples has revealed the SH2 domain as a hotspot in the mutational landscape of STAT proteins although the functional impact for the vast majority of these mutations remains poorly characterized. Despite several well resolved structures for SH2 domain-containing proteins, structural data regarding the distinctive STAT-type SH2 domain is limited. Here, we review the unique features of STAT-type SH2 domains in the context of all currently reported STAT3 and STAT5 SH2 domain clinical mutations. The genetic volatility of specific regions in the SH2 domain can result in either activating or deactivating mutations at the same site in the domain, underscoring the delicate evolutionary balance of wild type STAT structural motifs in maintaining precise levels of cellular activity. Understanding the molecular and biophysical impact of these disease-associated mutations can uncover convergent mechanisms of action for mutations localized within the STAT SH2 domain to facilitate the development of targeted therapeutic interventions.

Identifiants

pubmed: 31717342
pii: cancers11111757
doi: 10.3390/cancers11111757
pmc: PMC6895964
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Austrian Science Fund FWF
ID : I 4157
Pays : Austria
Organisme : CIHR
ID : MOP-137036
Pays : Canada
Organisme : CIHR
ID : MOP-130424
Pays : Canada

Références

Leukemia. 2019 Feb;33(2):415-425
pubmed: 30573779
Leukemia. 2019 Jul;33(7):1583-1597
pubmed: 30679796
Mol Cell Biol. 2004 Sep;24(18):8037-47
pubmed: 15340066
Br J Haematol. 2018 Mar;180(6):892-894
pubmed: 27984641
Nat Genet. 2015 Sep;47(9):1061-6
pubmed: 26192917
Blood. 2014 Aug 28;124(9):1460-72
pubmed: 24825865
Blood. 2016 Jun 16;127(24):3054-61
pubmed: 27034432
Leukemia. 2016 Jun;30(6):1311-9
pubmed: 26854024
Leukemia. 2018 Mar;32(3):774-787
pubmed: 28804127
Haematologica. 2014 Jul;99(7):e105-7
pubmed: 24837465
Blood. 2012 Oct 11;120(15):3048-57
pubmed: 22859607
FEBS Lett. 2013 Apr 2;587(7):833-9
pubmed: 23434585
J Hematol Oncol. 2013 Oct 31;6:82
pubmed: 24283217
Eur J Haematol. 2009 Nov;83(5):499-501
pubmed: 19624718
Mol Immunol. 2008 Nov;46(1):202-6
pubmed: 18706697
Blood. 2016 Dec 29;128(26):3061-3072
pubmed: 27799162
J Allergy Clin Immunol. 2008 Jul;122(1):181-7
pubmed: 18602572
J Allergy Clin Immunol. 2010 Feb;125(2):424-432.e8
pubmed: 20159255
Am J Surg Pathol. 2015 Dec;39(12):1719-1729
pubmed: 26379152
Blood. 2011 Mar 24;117(12):3409-20
pubmed: 21220747
Nat Commun. 2016 Sep 07;7:12602
pubmed: 27600764
Mod Pathol. 2016 Jan;29(1):43-50
pubmed: 26516697
Int J Lab Hematol. 2010 Aug 1;32(4):419-26
pubmed: 19968719
EMBO J. 2010 Jan 6;29(1):55-67
pubmed: 19851287
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
PLoS One. 2015 Nov 04;10(11):e0141906
pubmed: 26536348
FEBS Lett. 2012 Aug 14;586(17):2597-605
pubmed: 22569091
Haematologica. 2014 Oct;99(10):e188-92
pubmed: 24972766
Cancer Sci. 2014 Mar;105(3):342-6
pubmed: 24350896
J Allergy Clin Immunol. 2015 Nov;136(5):1411-3.e1-2
pubmed: 26292779
Blood. 2018 Sep 13;132(11):1146-1158
pubmed: 30054295
PLoS One. 2015 Dec 30;10(12):e0145142
pubmed: 26717567
ACS Med Chem Lett. 2013 Sep 08;4(11):1102-7
pubmed: 24900612
J Allergy Clin Immunol. 2016 Oct;138(4):1222-1224.e2
pubmed: 27345172
Oncogene. 2005 Aug 25;24(36):5552-60
pubmed: 16007214
Cancer Genet. 2015 Apr;208(4):115-28
pubmed: 25800665
Ann N Y Acad Sci. 2011 Jul;1229:29-37
pubmed: 21793836
Trends Biochem Sci. 1995 Nov;20(11):470-5
pubmed: 8578591
J Allergy Clin Immunol. 2010 Sep;126(3):611-7.e1
pubmed: 20816194
Leukemia. 2014 Aug;28(8):1738-42
pubmed: 24573384
Cancer Cell Microenviron. 2016;3(1):null
pubmed: 26973852
Nat Commun. 2018 Apr 19;9(1):1567
pubmed: 29674644
Cell. 1999 Aug 6;98(3):295-303
pubmed: 10458605
N Engl J Med. 2012 May 17;366(20):1905-13
pubmed: 22591296
Hum Pathol. 2018 Mar;73:74-81
pubmed: 29288042
Blood. 2018 Feb 22;131(8):935-939
pubmed: 29237593
Haematologica. 2018 Aug;103(8):e348-e350
pubmed: 29567772
Oncotarget. 2013 Jun;4(6):808-9
pubmed: 23868875
J Clin Immunol. 2013 Jul;33(5):896-902
pubmed: 23584561
Sci Rep. 2017 Apr 11;7(1):819
pubmed: 28400581
Medicine (Baltimore). 2012 Jul;91(4):e1-19
pubmed: 22751495
Nat Commun. 2015 Jan 14;6:6025
pubmed: 25586472
Leukemia. 2013 Jul;27(7):1598-600
pubmed: 23207521
Nat Genet. 2014 Aug;46(8):812-814
pubmed: 25038750
Leukemia. 2018 Aug;32(8):1713-1726
pubmed: 29728695
Blood. 2016 Dec 29;128(26):3020-3021
pubmed: 28034865
N Engl J Med. 2003 Sep 18;349(12):1139-47
pubmed: 13679528
Best Pract Res Clin Haematol. 2003 Sep;16(3):419-32
pubmed: 12935960
J Mol Diagn. 2014 Jul;16(4):382-92
pubmed: 24797340
Clin Immunol. 2011 Apr;139(1):75-84
pubmed: 21288777
Mol Endocrinol. 2013 Jan;27(1):150-61
pubmed: 23160480
Front Immunol. 2012 Aug 14;3:234
pubmed: 22912632
Blood. 2006 Jun 15;107(12):4898-906
pubmed: 16493008
Oncotarget. 2017 Jun 27;8(37):61876-61889
pubmed: 28977911
J Pharm Biomed Anal. 2019 Jan 5;162:60-65
pubmed: 30223143
Acta Oncol. 2013 Aug;52(6):1221-2
pubmed: 23317146
Blood. 2008 Mar 15;111(6):3173-82
pubmed: 18192505
Scand J Infect Dis. 2013 Mar;45(3):235-8
pubmed: 22992060
Leukemia. 2013 Nov;27(11):2244-7
pubmed: 23563237
Mol Cell. 2005 Mar 18;17(6):761-71
pubmed: 15780933
Haematologica. 2019 Mar;104(3):e104-e107
pubmed: 30337361
Eur J Immunol. 2011 Oct;41(10):3075-84
pubmed: 21792878
Haematologica. 2013 Nov;98(11):1748-52
pubmed: 23872306
EMBO J. 1999 Mar 1;18(5):1367-77
pubmed: 10064602
Haematologica. 2016 Sep;101(9):e387-90
pubmed: 27198716
N Engl J Med. 2007 Oct 18;357(16):1608-19
pubmed: 17881745
Blood. 2015 Jan 22;125(4):583-4
pubmed: 25614633
J Invest Dermatol. 2006 Oct;126(10):2272-80
pubmed: 16741510
Scand J Immunol. 2013 Sep;78(3):258-65
pubmed: 23659370
Cancer Genet. 2015 Jan-Feb;208(1-2):52-3
pubmed: 25749351
J Invest Dermatol. 2016 Jul;136(7):1490-1499
pubmed: 27039262
Eur J Pediatr. 2011 May;170(5):661-6
pubmed: 21107604
Annu Rev Med. 2015;66:311-28
pubmed: 25587654
Leukemia. 2014 Nov;28(11):2244-8
pubmed: 24947020
Indian J Pediatr. 2017 Jun;84(6):494-495
pubmed: 28315006
J Immunol. 2014 Aug 1;193(3):1142-50
pubmed: 24973454
J Biosci. 2012 Jun;37(2):243-57
pubmed: 22581330
J Exp Med. 2011 Jul 4;208(7):1359-66
pubmed: 21690253
J Clin Invest. 2018 Jan 2;128(1):387-401
pubmed: 29200404
Cancer Discov. 2017 Apr;7(4):369-379
pubmed: 28122867
Nat Med. 2007 Nov;13(11):1341-8
pubmed: 17922009
Clin Mol Allergy. 2011 Nov 29;9:14
pubmed: 22126402
Blood Adv. 2018 Sep 11;2(17):2199-2213
pubmed: 30185437
Blood. 2017 Feb 2;129(5):650-653
pubmed: 27956386
Blood. 2015 Jan 22;125(4):591-9
pubmed: 25359994
Mol Oncol. 2015 Jun;9(6):1194-206
pubmed: 25777967
Blood. 2016 Nov 17;128(20):2465-2468
pubmed: 27697773
Cell. 1993 Mar 12;72(5):767-78
pubmed: 7680959
Int Immunol. 2008 Mar;20(3):421-31
pubmed: 18270368
Br J Haematol. 2016 Apr;173(2):265-73
pubmed: 26917488
Nat Genet. 2015 Nov;47(11):1304-15
pubmed: 26437031
J Mol Diagn. 2010 Mar;12(2):213-9
pubmed: 20093388
Best Pract Res Clin Haematol. 2007 Sep;20(3):399-413
pubmed: 17707829
Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3801-4
pubmed: 9108058
Cancer Cell. 2015 Apr 13;27(4):516-32
pubmed: 25873174
Blood. 2016 May 19;127(20):2439-50
pubmed: 26813676
Blood. 2013 May 30;121(22):4541-50
pubmed: 23596048
J Allergy Clin Immunol. 2013 Aug;132(2):400-11.e9
pubmed: 23830147
Leuk Res Rep. 2014 Dec 16;4(1):4-7
pubmed: 25709890
J Exp Med. 2008 Jul 7;205(7):1551-7
pubmed: 18591410
J Pharm Biomed Anal. 2017 Sep 5;143:159-167
pubmed: 28600954
Growth Horm IGF Res. 2016 Jun;28:16-20
pubmed: 26703237
Blood. 2012 Apr 26;119(17):3997-4008
pubmed: 22403255
Mol Cell Proteomics. 2004 Jul;3(7):704-14
pubmed: 15073273
Nat Commun. 2015 Sep 29;6:8470
pubmed: 26415585
ChemMedChem. 2016 Apr 19;11(8):850-61
pubmed: 27028877
PLoS Genet. 2013;9(12):e1003997
pubmed: 24367274
Leukemia. 2018 May;32(5):1135-1146
pubmed: 29472718
J Biol Chem. 2006 Mar 10;281(10):6552-8
pubmed: 16303763
J Comput Aided Mol Des. 2015 May;29(5):451-70
pubmed: 25752764
Nat Commun. 2018 May 29;9(1):2105
pubmed: 29844444
Nat Commun. 2018 Feb 15;9(1):697
pubmed: 29449575
Cancer Res. 2003 Dec 15;63(24):9048-54
pubmed: 14695224
Nat Commun. 2019 Jun 7;10(1):2517
pubmed: 31175292

Auteurs

Elvin D de Araujo (ED)

Centre for Medicinal Chemistry, University of Toronto at Mississauga, Mississauga, ON L5L 1C6, Canada.
Department of Chemical & Physical Sciences, University of Toronto at Mississauga, Mississauga, ON L5L 1C6, Canada.

Anna Orlova (A)

Institute of Animal Breeding and Genetics, University of Veterinary Medicine, A-1210 Vienna, Austria.

Heidi A Neubauer (HA)

Institute of Animal Breeding and Genetics, University of Veterinary Medicine, A-1210 Vienna, Austria.

Dávid Bajusz (D)

Medicinal Chemistry Research Group, Research Center for Natural Sciences, 1117 Budapest, Hungary.

Hyuk-Soo Seo (HS)

Department of Cancer Biology, Dana-Farber Cancer Institute, Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Department of Biological Chemistry, Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.

Sirano Dhe-Paganon (S)

Department of Cancer Biology, Dana-Farber Cancer Institute, Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Department of Biological Chemistry, Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.

György M Keserű (GM)

Medicinal Chemistry Research Group, Research Center for Natural Sciences, 1117 Budapest, Hungary.

Richard Moriggl (R)

Institute of Animal Breeding and Genetics, University of Veterinary Medicine, A-1210 Vienna, Austria.

Patrick T Gunning (PT)

Centre for Medicinal Chemistry, University of Toronto at Mississauga, Mississauga, ON L5L 1C6, Canada.
Department of Chemical & Physical Sciences, University of Toronto at Mississauga, Mississauga, ON L5L 1C6, Canada.

Classifications MeSH